Table 3.
Biochemical markers (expressed as median values and interquartile range) in relation to the presence of carcinoma, patients' gender, and preoperative diagnosis.
| TC | P value | ||
|---|---|---|---|
| No | Yes | ||
| Total | |||
| TgAbs (ng/mL) | 20.00 (10.00–41.90) | 21.40 (12.25–91.66) | 0.657 |
| TPOAbs (U/mL) | 12.60 (5.15–29.65) | 10.35 (2.00–33.96) | 0.329 |
| Tg (ng/mL) | 58.00 (20.52–194.00) | 62.75 (21.43–421.5) | 0.696 |
| Age (years) | 50 (40–61) | 48 (38–61) | 0.785 |
| Females | |||
| TgAbs (ng/mL) | 21.38 (10.33–85.48) | 23.00 (12.50–89.40) | 0.695 |
| TPOAbs (U/mL) | 13.00 (5.00–36.34) | 8.70 (3.25–24.23) | 0.274 |
| Tg (ng/mL) | 57.75 (24.10–209.82) | 60.70 (18.55–204.80) | 0.715 |
| Age (years) | 50 (40–60) | 47 (37–60) | 0.623 |
| Males | |||
| TgAbs (ng/mL) | 14.68 (9.00–29.41) | 14.60 (8.40–1224.10) | 0.860 |
| TPOAbs (U/mL) | 10.98 (5.65–17.15) | 17.70 (1.50–102.35) | 0.875 |
| Tg (ng/mL) | 64.30 (12.40–146.90) | 216.80 (25.80–571.02) | 0.169 |
| Age (years) | 55 (41–63) | 60 (37–65) | 0.793 |
| Solitary nodule | |||
| TgAbs (ng/mL) | 21.37 (9.75–33.20) | 26.95 (14.60–98.45) | 0.364 |
| TPOAbs (U/mL) | 11.25 (3.67–21.04) | 18.00 (2.00–91.95) | 0.352 |
| Tg (ng/mL) | 27.00 (12.71–79.17) | 45.20 (24.08–503.57) | 0.253 |
| Age (years) | 42 (28–55) | 50 (27–66) | 0.422 |
| NTMG | |||
| TgAbs (ng/mL) | 19.80 (10.00–41.25) | 18.20 (10.00–89.40) | 0.966 |
| TPOAbs (U/mL) | 12.30 (4.18–24.85) | 6.25 (2.12–15.98) | 0.213 |
| Tg (ng/mL) | 56.60 (20.52–142.45) | 92.92 (16.75–461.35) | 0.380 |
| Age (years) | 50 (40–61) | 48 (39–61) | 0.751 |
TC: thyroid cancer; NTMG: nontoxic multinodular goiter; P value, Mann-Whitney U-test.